変数のクローン再定住ダイナミクスは,結腸直腸がんにおける化学療法反応に影響します
Antonija Kreso1, Catherine A O'Brien, Peter van Galen
1Campbell Family Institute, Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Science (New York, N.Y.)
|December 15, 2012
まとめ
同じ遺伝子クローン内の癌細胞は,機能的な違いを示します. この変動性は,遺伝的変化がない場合でも,腫瘍の成長と治療への反応に影響します.
科学分野:
- 腫瘍学 腫瘍学
- 癌生物学 癌生物学について
- 遺伝学 遺伝学とは
背景:
- 腫瘍内異質性は,遺伝的に多様なサブクローンによって引き起こされる癌の特徴です.
- 単一の遺伝子クローン内の細胞の機能的同等性は,まだ十分に理解されていません.
研究 の 目的:
- 結腸直腸がんにおける遺伝的に同一のクローン内の細胞間の機能的変動性を調査する.
- 非遺伝的要因が腫瘍細胞の行動と治療抵抗に寄与するかどうかを判断する.
主な方法:
- 腫瘍クローンを特徴づけるために,DNAコピー番号変異 (CNA) プロファイリングとシーケンシングを利用した.
- マウスの連続的な異種移植で150の単細胞系統のダイナミクスを監視するために,レンチウイルスの系統追跡を使用しました.
- クローン内のマークされた系統の増殖,持続性,および化学療法耐性を評価した.
主要な成果:
- クローンは,連続移植の間,遺伝的に安定したままでした.
- 増殖,持続性,および化学療法耐性の有意な機能的変動は,同じクローン内の系統間で観察されました.
- 化学療法による治療は,以前はマイナーまたは休眠状態だった系統の拡大を促した.
結論:
- 腫瘍細胞は,遺伝的多様性とは無関係に固有の機能的変動性を示す.
- この機能的な可塑性は,腫瘍の進行と治療の耐性に大きな影響を与えます.
- 非遺伝的多様性を理解することは,効果的ながん治療法の開発に不可欠です.
関連する概念動画
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...